Atavistik Bio is restoring protein function in disease with innovative approaches.

Atavistik Bio’s high-throughput platform for the unbiased identification of metabolite-protein interactions, will enable us to discover first-in-class drugs inspired and empowered by nature’s own mechanisms of allosteric control.

• Industry

  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2021

• Founders

  • Jared Rutter, PhD
  • Ralph J DeBerardinis, MD, PhD

  LUX Partners

  • Adam Goulburn